Related Experiment Video
Updated: Aug 4, 2026

Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
Histone deacetylase inhibitors are potent radiation protectants
Luca Paoluzzi1, William D Figg
1Division of Medical Oncology, Regina Elena Cancer Institute, Rome, Italy.
Abstract:
Radiation-induced acute and late injuries often represent a limit to the optimal delivery of radiotherapy in cancer patients. Chung et al. reported that histone deacetylase (HDAC) inhibitors, a novel class compound of gene modulators, might have a role in controlling different adverse effects from radiotherapy in preclinical models. They also showed how protection of normal tissues and inhibition of tumor growth might be possible at the same time.
Related Concept Videos
Drugs that Stabilize Microtubules
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Drugs that Destabilize Microtubules
Antiviral Nucleoside Inhibitors

